Second haematological cancer

Second haematological cancer predicts mortality in humans (HR 3.0, 95% CI 1.5–6.0; p=0.0023).

“second haematological cancer (3·0, 1·5-6·0; p=0·0023), and no response to treatment (2·8, 1·6-5·1; p=0·0006) as independent predictors of mortality.”

HumansErdheim-Chester disease; multivariable analysis

Phenotype, treatment, and determinants of prognosis in Erdheim-Chester disease: an international, retrospective, cohort study

The Lancet. Haematology·15 Oct 2026